Key Takeaways STXS released first clinical data on MAGiC catheter showing safety and efficacy in arrhythmia procedures. STXS' catheter showed 94% acute efficacy with low adverse event rates across 67 patients. MAGiC offers improved stability and precision, boosting confidence in STXS' robotic ablation tech.Stereotaxis (STXS) recently announced the publication of initial clinical results from its MAGiC catheter in the Journal of Interventional Cardiac Electrophysiology. The study, titled “First In-Human Re ...

Key Takeaways BSX's Endoscopy revenues rose 6% to $673M in Q1 2025, making up 14% of total company sales. Growth was fueled by strong global demand and high adoption of BSX's advanced GI treatment technologies. Boston Scientific's AXIOS, OverStitch, and MANTIS tools saw double-digit growth, driving segmental momentum.Boston Scientific’s (BSX) Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) conditions using innovative, less invasive technolo ...